Tuesday, January 14, 2025 1/14/2025

The Heart Failure Collaboratory Public-Private Partnership Between the United States Food and Drug Administration, the Inova Heart and Vascular Institute, and the Heart Failure Community

Award Number: R18FD006920
ORGANIZATION: FOOD AND DRUG ADMINISTRATION
OPDIV: FDA
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: KDA (KNOWLEDGE/DEVELOPMENT/APPLICATION)

Group Awards By:

View Award Abstract

The Heart Failure Collaboratory (HFC) is a public-private partnership between the Inova Heart and Vascular Institute (IHVI), the United States Food and Drug Administration (FDA), and the major stakeholders in the heart failure (HF) community, including patients, clinical investigators, academic leaders, pharmaceutical and device industry representatives, society representatives, third party payers, and government representatives from the United States National Institutes of Health (NIH) and Centers for Medicare and Medicaid Services (CMS). The HFC aims to advance scientific discussion, efficiency of clinical trials and evidence generation for HF, and foster development of therapies; to achieve these goals the HFC creates a collaborative environment in which FDA, government agencies including NIH and CMS, and the HF community can interact to optimize innovation and advancement of new therapeutic products. This proposal describes how the HFC executive committee, led by the program chair and principal investigator, in coordination with the HFC working groups, will continue to discuss and develop solutions to identified obstacles within the HF ecosystem. These include but are not limited to refining clinical trial endpoint definitions, facilitating standardized data collection and analyses, streamlining clinical trial performance by utilizing novel digital and automatic mechanisms, establishing systems to reward individuals, organizations, and networks with shared goals and dedication to advancing HF treatment, nurturing inclusion of patients and particularly those of diverse populations in all aspects of clinical research, and developing new diverse clinical research leaders and investigators. This application outlines the organizational infrastructure and support to be provided as the HFC strides into the future to overcome barriers to the development and implementation of new therapeutic interventions for patients with HF. It builds upon the initial successes of the public-private partnership between the FDA and IHVI administering the HFC, and further boosts the impact of the HFC to enhance clinical trial efficiency, therapeutic development, and patient wellbeing.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2024 ( Subtotal = $50,000 )
2024	2024	INOVA HEALTH CARE SERVICES	8095 INNOVATION PARK DR	FAIRFAX	VA	22031	FAIRFAX	USA	Food and Drug Administration Research	000	5	6/6/2024	NON-COMPETING CONTINUATION	$50,000
														Subtotal = $50,000

Issue Date FY: 2023 ( Subtotal = $0 )
2023	2023	INOVA HEALTH CARE SERVICES	8095 INNOVATION PARK DR	FAIRFAX	VA	22031	FAIRFAX	USA	Food and Drug Administration Research	001	4	4/5/2023	NON-COMPETING CONTINUATION	$0
2023	2021	INOVA HEALTH CARE SERVICES	8095 INNOVATION PARK DR	FAIRFAX	VA	22031	FAIRFAX	USA	Food and Drug Administration Research	000	2	12/19/2022	NON-COMPETING CONTINUATION	$0
														Subtotal = $0

Issue Date FY: 2022 ( Subtotal = $0 )
2022	2022	INOVA HEALTH CARE SERVICES	8110 GATEHOUSE RD STE 200E	FALLS CHURCH	VA	22042	FAIRFAX	USA	Food and Drug Administration Research	001	3	3/30/2022	NON-COMPETING CONTINUATION	$0
2022	2022	INOVA HEALTH CARE SERVICES	8110 GATEHOUSE RD STE 200E	FALLS CHURCH	VA	22042	FAIRFAX	USA	Food and Drug Administration Research	000	3	3/23/2022	NON-COMPETING CONTINUATION	$0
														Subtotal = $0

Issue Date FY: 2021 ( Subtotal = $499,244 )
2021	2021	INOVA HEALTH CARE SERVICES	8110 GATEHOUSE RD STE 200E	FALLS CHURCH	VA	22042	FAIRFAX	USA	Food and Drug Administration Research	000	2	3/31/2021	NON-COMPETING CONTINUATION	$499,244
														Subtotal = $499,244

Issue Date FY: 2020 ( Subtotal = $149,005 )
2020	2020	INOVA HEALTH CARE SERVICES	8110 GATEHOUSE RD STE 200E	FALLS CHURCH	VA	22042	FAIRFAX	USA	Food and Drug Administration Research	001	1	8/25/2020	NEW	-$149,005
2020	2020	INOVA HEALTH CARE SERVICES	8110 GATEHOUSE RD STE 200E	FALLS CHURCH	VA	22042	FAIRFAX	USA	Food and Drug Administration Research	000	1	4/6/2020	NEW	$149,005
2020	2020	INOVA HEALTH CARE SERVICES	8110 GATEHOUSE RD STE 200E	FALLS CHURCH	VA	22042	FAIRFAX	USA	Food and Drug Administration Research	002	1	8/26/2020	NEW	$149,005
2020	2020	INOVA HEALTH CARE SERVICES	8110 GATEHOUSE RD STE 200E	FALLS CHURCH	VA	22042	FAIRFAX	USA	Food and Drug Administration Research	003	1	9/2/2020	NEW	$0
														Subtotal = $149,005

Grand Total All Awards = $698,249

Top

All Categories

About

Search

Reports

Data Submission

Award Information

The Heart Failure Collaboratory Public-Private Partnership Between the United States Food and Drug Administration, the Inova Heart and Vascular Institute, and the Heart Failure Community

Award Number: R18FD006920

ORGANIZATION: FOOD AND DRUG ADMINISTRATION

OPDIV: FDA

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: KDA (KNOWLEDGE/DEVELOPMENT/APPLICATION)

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer